Clinical Characteristics of Patients Under Investigation For COVID-19 In Emergency Department

Authors

  • Phatcharanicha Duandern Emergency Department, Koh Samui Hospital
  • Kiattichai Daorattanachai Department of emergency medicine, faculty of medicine, Thammasat university

Keywords:

COVID-19, clinical characteristic, emergency department

Abstract

Introduction
The COVID-19 pandemic caused by SARS-CoV-2 infection poses a substantial public health challenge. Understanding the clinical features of patients presenting at the emergency department (ED) who meet the screening and investigation criteria for the novel coronavirus is crucial for accurate diagnosis and management. This study aimed to assess the clinical characteristics and identify risk factors among patients undergoing screening for SARS-CoV-2 infection.

Methods
In this retrospective analytical study, data were collected from 313 patients who visited the ED of Thammasat University Hospital between March 1, 2020, and July 31, 2021. The collected data were analyzed for the patients’ clinical characteristics, risk factors, and treatment outcomes using univariate and logistic regression analysis.

Results
Of the 313 patients, 100 had COVID-19. Among the cases, 22.36% had a history of exposure to individuals exhibiting fever or flu-like symptoms within a 14-day period. The main symptoms were dyspnea, fever, cough, and rhinorrhea (76.04%, 64.86%, 52.08%, and 13.74%, respectively). Additionally, 55.91% of patients had low oxygen saturation (≤80%), while 83.90% showed abnormalities in chest X-ray. Respiratory support was provided to 66% of the patients. The majority of patients (89.14%) were admitted to the hospital, and mortality rate was 20.13%. The study identified a higher body mass index (BMI) of ≥40 kg/m2, oxygen saturation≤80%, rhinorrhea, dyspnea and exposure to individuals with fever or flu-like symptoms within 14 days as risk factors for COVID-19.

Conclusion
Dyspnea, fever, cough, rhinorrhea and desaturation were important signs for patients undergoing investigations for COVID-19. A significant risk factor was close contact with individuals exhibiting fever or flu-like symptoms within 14 days.

References

WHO COVID-19 Overview 2023 [cited 2023 21 April]. Available from: https://covid19.who.int.

Bohn MK, Hall A, Sepiashvili L, Jung B, Steele S, Adeli K. Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression. Physiology (Bethesda). 2020;35(5):288-301.

Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med. 2020;382(24):2372-4.

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20.

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-90.

กรมควบคุมโรค. นิยามผู้สงสัยติดเชื้อไวรัสโคโรนา 2019 ที่เข้าเกณฑ์สอบสวนโรค (Patient Under Investigation : PUI) นนทบุรี 2563 [cited 2563 20 สิงหาคม]. Available from: https://ddc.moph.go.th/viralpneumonia/file/gsrrt/gsrrt010563.pdf

Johnson KD, Harris C, Cain JK, Hummer C, Goyal H, Perisetti A. Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19. Front Med (Lausanne). 2020;7:526.

Peyrony O, Marbeuf-Gueye C, Truong V, Giroud M, Rivière C, Khenissi K, et al. Accuracy of Emergency Department Clinical Findings for Diagnosis of Coronavirus Disease 2019. Ann Emerg Med. 2020;76(4):405-12.

Capon A, Ousta D, Ferson M, Ingleton A, Sheppeard V. A multiple site community outbreak of COVID-19 in Sydney, Australia. Aust N Z J Public Health. 2021;45(2):129-32.

Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(8):911-9.

Liu T, Gong D, Xiao J, Hu J, He G, Rong Z, et al. Cluster infections play important roles in the rapid evolution of COVID-19 transmission: A systematic review. Int J Infect Dis. 2020;99:374-80.

Albashir AAD. The potential impacts of obesity on COVID-19. Clin Med (Lond). 2020;20(4):e109-e13.

Huang Y, Lu Y, Huang YM, Wang M, Ling W, Sui Y, et al. Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism. 2020;113:154378.

Daorattanachai K, Hirunrut C, Pirompanich P, Weschawalit S, Srivilaithon W. Association of Monocyte Distribution Width with the Need for Respiratory Support in Hospitalized COVID-19 Patients. Indian J Crit Care Med. 2023;27(5):352-7.

Litmanovich DE, Chung M, Kirkbride RR, Kicska G, Kanne JP. Review of Chest Radiograph Findings of COVID-19 Pneumonia and Suggested Reporting Language. J Thorac Imaging. 2020;35(6):354-60.

Gattinoni L, Gattarello S, Steinberg I, Busana M, Palermo P, Lazzari S, et al. COVID-19 pneumonia: pathophysiology and management. Eur Respir Rev. 2021;30(162).

Downloads

Published

2023-12-14

How to Cite

1.
Duandern P, Daorattanachai K. Clinical Characteristics of Patients Under Investigation For COVID-19 In Emergency Department. TJEM [Internet]. 2023 Dec. 14 [cited 2024 Nov. 24];5(1):33-50. Available from: https://he02.tci-thaijo.org/index.php/TJEM/article/view/263432

Issue

Section

RESEARCH ARTICLE

Categories